Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Gross Profit: 2019-2025

Historic Gross Profit for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to $7.9 million.

  • Eton Pharmaceuticals' Gross Profit rose 24.64% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 million, marking a year-over-year increase of 75.62%. This contributed to the annual value of $23.4 million for FY2024, which is 11.16% up from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Gross Profit is $7.9 million, which was down 34.12% from $11.9 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Gross Profit registered a high of $11.9 million during Q2 2025, and its lowest value of $121,000 during Q3 2021.
  • Moreover, its 3-year median value for Gross Profit was $6.3 million (2024), whereas its average is $6.7 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Gross Profit skyrocketed by 343,666.67% in 2021 and then slumped by 87.13% in 2022.
  • Quarterly analysis of 5 years shows Eton Pharmaceuticals' Gross Profit stood at $5.7 million in 2021, then rose by 11.17% to $6.4 million in 2022, then plummeted by 42.92% to $3.6 million in 2023, then skyrocketed by 78.40% to $6.5 million in 2024, then increased by 24.64% to $7.9 million in 2025.
  • Its Gross Profit was $7.9 million in Q3 2025, compared to $11.9 million in Q2 2025 and $9.9 million in Q1 2025.